Online Business

Sun Pharma gets USFDA nod for anti hypertensive drug

Sun Pharmaceutical Industries today said it has got the approval for its Abbreviated New Drug Application (ANDA) for the generic version of Quinapril Hydrochloride tablets used in the treatment of hypertension and congested heart failure. - Step up vigil to stop fake Made-in-India drugs in Africa: govt - Report on pharma innovation to be released at USIBC meet - Apex Court overrules HC order favouring Gufic Ltd - Novartis says produces first batch of H1N1 vaccine - Zydus Cadila files anti-diabetic drug application with DCGI - Glenmark gets US regulatory nod for anti-hypertension tablets The Quinapril Hydrochloride Tablets are generic version of "Accupril" tablets from Pfizer"s portfolio and are available in four strengths, the company said in a filing to Bombay Stock Exchange. The drug have annual sales of approximately $45 million in US, it added.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Gold Q3 demand dip by 49%: WGC
Demand for gold waned by 49 per cent in the third quarter this year over the corresponding period last year, thanks to a surge in its prices, the World Gold Council (WGC) said today.
Popular Articles

3G spectrum auction on schedule: Raja
The auction of 3G spectrum is on track and the empowered group of ministers (EGoM) will take a decision on the number of slots to be sold, Telecom Minister A Raja said today.

Over 15 PwC tax professionals quit; to join rival KPMG
Over 15 senior executives of the PricewaterhouseCoopers (PwC), whose Bangalore-based arm audited accounts of scam-hit Satyam Computer Services, have quit and would be joining PwC"s global rival KPMG.